The discount to KIMS has been assigned in comparison to the aforementioned peers on the back of high concentration risk with around 2/3rd of the company’s sales being accounted for by Hyderabad and higher execution risks given the investment phase lined up over the next few years.
The domestic pharmaceutical player announced its acquisition of Curatio Healthcare for Rs 2,000 crore to strengthen its presence in the dermatology segment. It has entered into a definitive agreement to acquire 100 per cent stake, the company said in an exchange filing.
For the quarter ended June 30, 2022, the company has reported a consolidated total income of Rs 1567.30 crore, up 10.75 per cent from last quarter total income of Rs 1415.20 crore and up 28.31 per cent from last year same quarter total income of Rs 1221.50 crore.
The Relative Strength Index of the stock stood at 29.69 on Wednesday.
The region extended Tuesday's losses, with London's benchmark FTSE 100 index tumbling 1.6 percent to 6,870.45 points.In the eurozone, Frankfurt's DAX index dived 1.3 percent to 11,978.14 points and the Paris CAC 40 shed 1.4 percent to 5,672.99.
A total of 13,220 shares changed hands on the counter till 01:14PM (IST).
The stock quoted a 52-week high price of Rs 1081.0 and a 52-week low of Rs 697.05.
The Relative Strength Index of the stock stood at 57.71 on Wednesday.
A total of 252,122 shares changed hands on the counter till 11:11AM (IST)